After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2023 Financial Results.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Neurocrine Biosciences, Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. At the end of the last regular session, the stock closed at $139.80 and fluctuated between $140.30 as its day high and $137.21 as its day low. The current market capitalization of Neurocrine Biosciences, Inc. is $13.74B. A total of 0.83 million shares were traded on the day, compared to an average of 748.89K shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, NBIX has seen 2 BUY and 5 SELL insider trades, representing the acquisition of 24,000 and the disposition of 46,750 shares. Over the last 12 months, there were 7 BUYs and 79 SELLs from insiders. Insiders purchased 54,000 shares during that period but sold 330,403.
In the most recent transaction, GORMAN KEVIN CHARLES sold 62,023 shares of NBIX for 134.01 per share on Jan 09. After the transaction, the Chief Executive Officer now owns 499,754 company shares. In a previous transaction on Jan 08, GORMAN KEVIN CHARLES sold 105,835 shares at 132.44 per share. NBIX shares that Chief Executive Officer owns now total 499,754.
Among the insiders who sold shares, Gano Kyle disposed of 75,000 shares on Jan 02 at a per-share price of $131.47. This resulted in the Chief Business Development Off holding 130,250 shares of NBIX after the transaction. In another insider transaction, RASTETTER WILLIAM H sold 11,044 shares at $131.47 per share on Jan 02. Company shares held by the Director now total 51,741.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for NBIX in the last 3 months, the mean price target is $140.44 with high estimates of $170.00 and low estimates of $100.00. In terms of 52-week highs and lows, NBIX has a high of $139.56 and a low of $89.04.
As of this writing, NBIX has an earnings estimate of $1.13 per share for the current quarter. EPS was calculated based on a consensus of 18 estimates, with a high estimate of $1.44 per share and a lower estimate of $0.42. The company reported an EPS of $0.95 in the last quarter, which was 21.80% higher than expectations of $0.78.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. NBIX’s latest balance sheet shows that the firm has $711.30M in Cash & Short Term Investments as of fiscal 2021. There were $440.40M in debt and $245.80M in liabilities at the time. Its Book Value Per Share was $20.39, while its Total Shareholder’s Equity was $1.37B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NBIX is Buy with a score of 4.48.
